Search Results - "Carmona, Eva"

COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies by Salian, Vrishali S, Wright, Jessica A, Vedell, Peter T, Nair, Sanjana, Li, Chenxu, Kandimalla, Mahathi, Tang, Xiaojia, Carmona Porquera, Eva M, Kalari, Krishna R, Kandimalla, Karunya K

“…At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a global pandemic, was identified in the Chinese city of Wuhan. Although…”
Get full text

The Role of Infection in Interstitial Lung Diseases: A Review by Azadeh, Natalya, Limper, Andrew H, Carmona, Eva M, Ryu, Jay H

“…Interstitial lung disease (ILD) comprises an array of heterogeneous parenchymal lung diseases that are associated with a spectrum of pathologic, radiologic,…”
Get full text

Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection by Huang, Su, Goplen, Nick P, Zhu, Bibo, Cheon, In Su, Son, Youngmin, Wang, Zheng, Li, Chaofan, Dai, Qigang, Jiang, Li, Xiang, Min, Carmona, Eva M, Vassallo, Robert, Limper, Andrew H, Sun, Jie

“…Influenza virus causes a heterogeneous respiratory infectious disease ranging from self-limiting symptoms to non-resolving pathology in the lungs. Worldwide,…”
Get full text

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline by Hage, Chadi A, Carmona, Eva M, Epelbaum, Oleg, Evans, Scott E, Gabe, Luke M, Haydour, Qusay, Knox, Kenneth S, Kolls, Jay K, Murad, M Hassan, Wengenack, Nancy L, Limper, Andrew H

“…Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of…”
Get full text

36-Year-Old Woman With Progressive Dyspnea, Cough, and Chills by Ellis, Megan M, Ahmed, Nayla, Carmona, Eva M

Get full text

Overview of Treatment Approaches for Fungal Infections by Carmona, Eva M., MD, PhD, Limper, Andrew H., MD

“…Invasive fungal diseases cause high morbidity and mortality in an immunocompromised host. Antifungals are the drugs of choice and can be divided in 4 main…”
Get full text

When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis by Zamora, Ana C, Ortega, Victor E, Carmona, Eva M

Get full text

Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study by Ungprasert, Patompong, Carmona, Eva M, Utz, James P, Ryu, Jay H, Crowson, Cynthia S, Matteson, Eric L

“…To characterize the epidemiology of sarcoidosis from 1946 through 2013. An inception cohort of patients with incident sarcoidosis from January 1, 1976, through…”
Get full text

Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans by Kottom, Theodore J, Carmona, Eva M, Limper, Andrew H

“…the fungus that causes pneumonia (PJP), is a leading cause of morbidity and mortality in immunocompromised individuals. We have previously shown that lung…”
Get full text

Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy by Kottom, Theodore J, Carmona, Eva M, Limper, Andrew H

“…cyst life forms contain abundant β-glucan carbohydrates, synthesized using β-1,3 and β-1,6 glucan synthase enzymes and the donor uridine diphosphate…”
Get full text

Pneumocystis Pneumonia in Patients Treated With Rituximab by Martin-Garrido, Isabel, MD, Carmona, Eva M., MD, PhD, Specks, Ulrich, MD, Limper, Andrew H., MD, FCCP

“…Background Pneumocystis pneumonia (PcP) is an opportunistic fungal infection. Although T-cell immunity is classically related to Pneumocystis defense, recent…”
Get full text

EphA2 Is a Lung Epithelial Cell Receptor for Pneumocystis β-Glucans by Kottom, Theodore J, Schaefbauer, Kyle, Carmona, Eva M, Limper, Andrew H

“…Abstract Pneumocystis species interaction with myeloid cells is well known, especially in macrophages; however, how the organism binds to lung epithelial cells…”
Get full text

Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study by Ungprasert, Patompong, Carmona, Eva M., Crowson, Cynthia S., Matteson, Eric L.

“…Purpose Sarcoidosis is a disease with heterogenous clinical presentations. Diagnosis of sarcoidosis is often challenging with the lack of gold standard tests…”
Get full text

48-Year-Old Man With Bilateral Mediastinal Lymphadenopathy, Orbital Pseudotumors, Kidney Masses, and Acute Pancreatitis by Albitar, Hasan Ahmad Hasan, Carmona, Eva M.

“…A 48-year-old man with a history of chronic rhinosinusitis, gastroesophageal reflux disease, and dietcontrolled non-insulin-dependent diabetes mellitus…”
Get full text

Gene expression in lung epithelial cells following interaction with Pneumocystis carinii and its specific life forms yields insights into host gene responses to infection by Kottom, Theodore J., Carmona, Eva M., Limper, Andrew H.

“…Pneumocystis spp. interacts with epithelial cells in the alveolar spaces of the lung. It is thought that the binding of Pneumocystis to host cell epithelium is…”
Get full text

CLEC4A and CLEC12B C-type lectin receptors mediate interactions with Pneumocystis cell wall components by Kottom, Theodore J, Carmona, Eva M, Schaefbauer, Kyle, Limper, Andrew H

“…C-type lectin receptors (CLRs) are prominently expressed on myeloid cells where they perform multiple functions including serving as pattern recognition…”
Get full text

Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans by Kottom, Theodore J, Carmona, Eva M, Limper, Andrew H

“…, the opportunistic fungus that causes pneumonia (PCP) in humans, is a significant contributor to morbidity and mortality in immunocompromised patients. Given…”
Get full text

Pulmonary Sarcoidosis: Diagnosis and Treatment by Carmona, Eva M., MD, PhD, Kalra, Sanjay, MD, Ryu, Jay H., MD

“…Abstract Sarcoidosis is a chronic granulomatous disease of unknown cause that is seen worldwide and occurs mainly in patients between the ages of 20 and 60…”
Get full text

Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry by Shlobin, Oksana A, Kouranos, Vasilis, Barnett, Scott D, Alhamad, Esam H, Culver, Daniel A, Barney, Joseph, Cordova, Francis C, Carmona, Eva M, Scholand, Mary Beth, Wijsenbeek, Marlies, Ganesh, Sivagini, Lower, Elyse E, Engel, Peter J, Wort, John, Price, Laura, Wells, Athol U, Nathan, Steven D, Baughman, Robert P

“…Sarcoidosis-associated pulmonary hypertension (SAPH) is associated with reduced survival in single-centre studies. The international Registry for SAPH (ReSAPH)…”
Get full text

Canonical Stimulation of the NLRP3 Inflammasome by Fungal Antigens Links Innate and Adaptive B-Lymphocyte Responses by Modulating IL-1β and IgM Production by Ali, Mohamed F, Dasari, Harika, Van Keulen, Virginia P, Carmona, Eva M

“…The NLRP3 inflammasome is activated in response to different bacterial, viral, and fungal pathogens and serves as modulator of different pattern recognition…”
Get full text